Skip to content

Intermittent sacral neuromodulation for treatment of idiopathic overactive bladder in women

Intermittent sacral neuromodulation for treatment of idiopathic overactive bladder in women - Intermittent sacral neuromodulation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON40167
Enrollment
16
Registered
2014-04-30
Start date
2014-07-14
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

overactive bladder urinary incontinence

Interventions

In all patients the implantable neurostimulator will be automatically turnes off for 18 hours a day.

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - written informed consent - sufficient knowledge of the Dutch language to understand the informed consent form and to complete the questionnaires - female at least 18 years of age - subjective successful treatment for at least 6 months through sacral neuromodulation using InterStim for OAB - at least three months of anticholinergic treatment without result or had to stop anticholinergic treatment because of adverse side effects before implantation of the neuromodulator - currently not using anticholinergic or other medical treatment for idiopathic OAB - last intravesical Botox treatment at least 12 months ago

Exclusion criteria

Exclusion criteria: - neuropathic bladder - symptomatic urinary tract infection - indwelling catheter or clean intermittent catheterization - implantable neurostimulator of which the estimated service life of the battery is less than 1 year at the moment of inclusion in the study - radiation therapy of the pelvis - (previous) bladder cancer

Design outcomes

Primary

MeasureTime frame
The primary endpoint will be incontinence episodes per day compared to baseline.

Secondary

MeasureTime frame
- Urinary frequency per 24 hours - Number of pads used - Average volume per voiding This will be derived from the voiding diaries. The change from baseline to intermittent stimulation will be determined. The difference between intermittent and continuous stimulation will also be determined, for incontinence episodes per day as well. Standard scores derived from the questionnaires (IIQ-7, UDI-6, PFDI-20, PFIQ-7, PISQ, EuroQOL-5, FICI, FIQL): - Change from baseline to intermittent stimulation. - Difference between intermittent and continuous stimulation.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)